Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Julia E. McGuinness"'
Autor:
Sungsoo Kim, Jessica Armand, Anton Safonov, Mimi Zhang, Rajesh K. Soni, Gary Schwartz, Julia E. McGuinness, Hanina Hibshoosh, Pedram Razavi, Minah Kim, Sarat Chandarlapaty, Hee Won Yang
Publikováno v:
Cell Reports, Vol 42, Iss 11, Pp 113198- (2023)
Summary: Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) are key therapeutic agents in the management of metastatic hormone-receptor-positive breast cancer. However, the emergence of drug resistance limits their long-term efficacy. Here, we show
Externí odkaz:
https://doaj.org/article/ad5bf604ff2245b3b34e9324275ec4e4
Autor:
Rita Kukafka, Mari Millery, Samuel Pan, Thomas B. Silverman, Tianmai Zhang, Julia E. McGuinness, Katherine D. Crew, Alejandra N. Aguirre
Publikováno v:
Humanities & Social Sciences Communications, Vol 10, Iss 1, Pp 1-11 (2023)
Abstract A cross-sectional survey was conducted among high-risk, racially/ethnically diverse adults at the point in time when New York City (NYC) became the COVID-19 pandemic’s global epicenter. The study objective was to assess the threat and copi
Externí odkaz:
https://doaj.org/article/3c02c10719444d8282b71c379ab1754d
Autor:
Tarsha Jones, Thomas Silverman, Ashlee Guzman, Julia E. McGuinness, Meghna S. Trivedi, Rita Kukafka, Katherine D. Crew
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background Chemoprevention with anti-estrogens, such as tamoxifen, raloxifene or aromatase inhibitors, have been shown to reduce breast cancer risk in randomized controlled trials; however, uptake among women at high-risk for developing brea
Externí odkaz:
https://doaj.org/article/20718736b05246f3b01af35db5b201b5
Autor:
Vicky Ro, Tarsha Jones, Thomas Silverman, Julia E. McGuinness, Ashlee Guzman, Jacquelyn Amenta, Rita Kukafka, Katherine D. Crew
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background U.S. professional organizations have provided conflicting recommendations on annual vs. biennial mammography screening. Potential harms of more frequent screening include increased anxiety and costs of false positive results, incl
Externí odkaz:
https://doaj.org/article/74df7720657342d0a9420e6d2029bb11
Autor:
Andreas Varkaris, Erika Hamilton, Jason Henry, Alexander I. Spira, Alison M. Schram, Julia E. McGuinness, Gege Tan, Xiaoyan Li, Tamieka Hunter, Ramin Samadani, Alison Timm, Djuro Karanovic, Vivek Subbiah, Cesar A. Perez
Publikováno v:
Cancer Research. 83:OT3-22
Background: Targeting constitutively active mutant kinases with selective small molecule inhibitors is a key therapeutic pillar of precision oncology. Phosphatidylinositol-4,5bisphosphate-3 kinase, catalytic subunit alpha (PIK3CA) mutations leading t
Autor:
Jingwen Zhang, Julia E. McGuinness, Xin He, Tarsha Jones, Thomas Silverman, Ashlee Guzman, Benjamin L. May, Rita Kukafka, Katherine D. Crew
Publikováno v:
American Journal of Preventive Medicine. 64:51-60
In 2009, the U.S. Preventive Services Task Force updated recommended mammography screening frequency from annual to biennial for average-risk women aged 50-74 years. The association between estimated breast cancer risk and mammography screening frequ
Autor:
Alissa Michel, Vicky Ro, Julia E. McGuinness, Simukayi Mutasa, Mary Beth Terry, Parisa Tehranifar, Benjamin May, Richard Ha, Katherine D. Crew
Publikováno v:
Breast Cancer Research and Treatment.
Autor:
Katherine D. Crew, Gauri Bhatkhande, Thomas Silverman, Jacquelyn Amenta, Tarsha Jones, Julia E. McGuinness, Jennie Mata, Ashlee Guzman, Ting He, Jill Dimond, Wei-Yann Tsai, Rita Kukafka
Publikováno v:
Cancer Prev Res (Phila)
Significant underutilization of breast cancer chemoprevention remains, despite guidelines stating that physicians should recommend chemoprevention with antiestrogen therapy to high-risk women. We randomized women, ages 35 to 75 years, who met high-ri
Autor:
Meghna S. Trivedi, Melissa K. Accordino, Fabio M. Iwamoto, Deanna Fisher, Lan Huynh, Kathleen Fenn, Julie Ann Mayer, Kevin Kalinsky, Dawn L. Hershman, Julia E. McGuinness, David Cieremans, Edgar V. Sales, Mary Welch, Margaux Wooster, Robbie Schultz, Shing Lee, Lauren Franks, Teri N. Kreisl, Andrew B. Lassman, Katherine D. Crew, Veena M. Singh, Aya Haggiagi
Publikováno v:
Clin Breast Cancer
Diagnosis of LM is limited by low sensitivity of cerebrospinal fluid (CSF) cytopathology. Detecting tumor cells in CSF (CSF-TCs) might be more sensitive. We evaluated if CNSide (CNSide), a novel assay for tumor cell detection in CSF, can detect CSF-T
Autor:
Julia E. McGuinness, Vicky Ro, Simukayi Mutasa, Samuel Pan, Jianhua Hu, Meghna S. Trivedi, Melissa K. Accordino, Kevin Kalinsky, Dawn L. Hershman, Richard S. Ha, Katherine D. Crew
Publikováno v:
Breast Cancer Research and Treatment. 194:35-47